Skip to Content

Columbia Adaptive Risk Allocation Inst CRAZX Fund Analysis

| Medalist Rating as of | See Columbia Threadneedle Investment Hub

Morningstar’s Analysis CRAZX

Will CRAZX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Columbia Adaptive Risk Allocation Inst's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor